Active Ingredient History

  • Now
Cariprazine is an antipsychotic approved by FDA for the treatment of schizophrenia and bipolar I disorder. The drug has a unique clinical action which is explained by its ability to act on dopamine D3 receptors. Pharmacology studies revealed that cariprazine is a dual partial agonist of dopamine D2 and D3 receptors as well as serotonin 5HT1a, 2a and 2b receptors.   NCATS

  • SMILES: CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1
  • Mol. Mass: 427.42
  • ALogP: 4.34
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$30.0015 - $40.5178
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

cariprazine | cariprazine hcl | cariprazine hydrochloride | mp-214 | rgh-188 | rgh-188 hcl | trans-4-(2-(4-(2,3-dichlorophenyl)piperazine-1-yl)-ethyl)-n,n-dimethylcarbamoyl-cyclohexyl-amine hydrochloride | trans-n-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-n’,n’-dimethylurea hydrochloride | vraylar


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue